Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance

MLA

Cham Jung, et al. “Anti-Disialoganglioside Antibody Internalization by Neuroblastoma Cells as a Mechanism of Immunotherapy Resistance.” Cancer Immunology, Immunotherapy, vol. 71, May 2021, pp. 153–64. EBSCOhost, https://doi.org/10.1007/s00262-021-02963-y.

APA

Cham Jung, Rachelle Tibbetts, Tania Porras-Corredor, Sakunthala Muthugounder, Meng-Hua Lee, Shahab Asgharzadeh, Kee Kiat Yeo, & Michael A. Sheard. (2021). Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance. Cancer Immunology, Immunotherapy, 71, 153–164. https://doi.org/10.1007/s00262-021-02963-y

Chicago

Cham Jung, Rachelle Tibbetts, Tania Porras-Corredor, Sakunthala Muthugounder, Meng-Hua Lee, Shahab Asgharzadeh, Kee Kiat Yeo, and Michael A. Sheard. 2021. “Anti-Disialoganglioside Antibody Internalization by Neuroblastoma Cells as a Mechanism of Immunotherapy Resistance.” Cancer Immunology, Immunotherapy 71 (May): 153–64. doi:10.1007/s00262-021-02963-y.